Cargando…
Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
Alzheimer’s disease (AD) is the most common cause of dementia in the general population and, to date, constitutes a major therapeutic challenge. In the pathogenesis of AD, aggregates of amyloid β (Aβ) and neurofibrillary tangles (NFTs) containing Tau-microtubule-associated protein (tau) are known to...
Autores principales: | Barczuk, Julia, Siwecka, Natalia, Lusa, Weronika, Rozpędek-Kamińska, Wioletta, Kucharska, Ewa, Majsterek, Ireneusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409081/ https://www.ncbi.nlm.nih.gov/pubmed/36012243 http://dx.doi.org/10.3390/ijms23168979 |
Ejemplares similares
-
GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance
por: Granek, Zuzanna, et al.
Publicado: (2023) -
IRE1α Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies
por: Wiese, Wojciech, et al.
Publicado: (2022) -
PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities
por: Wiese, Wojciech, et al.
Publicado: (2023) -
Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy
por: Siwecka, Natalia, et al.
Publicado: (2023) -
The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
por: Rozpędek-Kamińska, Wioletta, et al.
Publicado: (2021)